Lavo Life Sciences
DefunctYC W23Founded 2022 · 3 employees · 3 known investors
Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
Founders & leadership· Y Combinator alumni (W23)
Lavo Life Sciences was founded in 2022 by Scott Swarthout, Zach Glick, and Derek Metcalf.
SS
Scott SwarthoutinCEO, Co-Founder (Acquired by Dayhoff Labs)2022–2025Scott Swarthout is the founder and CEO of Lavo Life Sciences, which provides computational molecular simulation services to pharmaceutical companies.
ZG
Zach GlickinFounder
Investors · 3
In the news
Frequently asked questions
- What does Lavo Life Sciences do?
- Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
- Who founded Lavo Life Sciences?
- Lavo Life Sciences was founded by Scott Swarthout, Zach Glick, Derek Metcalf in 2022.
- Who are Lavo Life Sciences's investors?
- Lavo Life Sciences's investors include Eastlink Capital Partners, Undeterred Capital, Y Combinator.